Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer

Clinical trial NCT04390399 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04390399
Sponsor: ImmunityBio, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2020-07-21
Primary completion: 2025-10-13
Enrollment: 328

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.